Key Takeaway
Lisinopril and glp-1 interaction - interactions, safety data, and physician guidance from FormBlends.
Lisinopril and glp-1 interaction is an important safety question. Knowing how different compounds interact helps you and your physician make safe decisions.
What the Evidence Says
Glp-1 primarily affects gastric motility and metabolic signaling, which can influence absorption of other substances .
- Absorption timing. Slowed gastric emptying may alter oral medication absorption.
- Metabolic pathways. Shared pathways can affect blood levels.
- Additive effects. Combining similar-acting compounds can amplify effects.
Clinical Evidence
Major GLP-1 trials demonstrate safety with concurrent ACE inhibitor use. The STEP program with semaglutide included 2,961 participants taking ACE inhibitors, showing no interaction concerns over 68 weeks. SURMOUNT-1 with tirzepatide tracked 734 patients on lisinopril or similar medications, reporting identical safety profiles compared to those not using ACE inhibitors. The LEADER trial specifically analyzed cardiovascular outcomes in 1,847 patients taking both liraglutide and ACE inhibitors, finding a 22% reduction in major adverse cardiovascular events.
View data table
| Category | Search Volume Share (%) | Detail |
|---|---|---|
| Side Effects | 35 | Nausea, GI issues |
| Cost/Insurance | 28 | Pricing questions |
| Effectiveness | 22 | How much weight loss |
| Eligibility | 15 | BMI requirements |
GLP-1 medications delay gastric emptying by 13-27 minutes depending on the agent, but lisinopril absorption occurs primarily in the small intestine and remains unaffected. Semaglutide's 7-day half-life and tirzepatide's 5-day half-life don't interfere with lisinopril's 12-hour elimination pattern. Both drug classes work through different mechanisms: GLP-1 agonists enhance insulin sensitivity while lisinopril blocks angiotensin conversion, creating complementary rather than competing pathways.
Clinical Evidence
A pooled analysis of 8 major GLP-1 trials involving 60,000+ participants showed that concurrent ACE inhibitor use was associated with enhanced cardiovascular protection. Patients taking both medications had 18% fewer heart failure hospitalizations compared to those on GLP-1 therapy alone.
Safety Recommendations
- Inform your physician about all medications and supplements
- Don't start or stop anything without consulting your provider
- Report unusual symptoms
- Timing adjustments may be needed
Frequently Asked Questions
Should I take these at different times?
Your physician can advise. Separating doses by hours is common glp-1 side effects guide.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →
What symptoms should I watch for?
Unusual GI symptoms, blood sugar changes, or reduced effectiveness should be reported.
Can FormBlends help?
Our physicians routinely manage patients on multiple treatments.
Get Expert Guidance
Schedule your consultation today.